At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,234 enrolled
Drug / intervention
Topiramatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Observational, Multi-center Study to Assess Long-term Retention Rate of Topiramate in Patients With Epilepsy
In Brief
An observational study evaluating Topiramate for Epilepsy. Completed, enrolled 1,234 participants.
Detailed Summary
The purpose of this study is to evaluate the long-term retention rate of topiramate in participants with epilepsy (seizure disorder).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
Primary CompletionMay 2009
First PostedSep 2012
TodayJul 2026
First PostedSep 11, 2012
Enrollment StartJul 1, 2007
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.8 years ago
Interventions
Topiramatedrug
This is an observational study. Participants with seizures receiving topiramate as per Investigator's discretion will be observed.